Servi
`-s
`Digital Access Service
`(DAS)
`
`WIPO
`WORLD
`INTELLECTUAL PROPERTY
`ORGANIZATION
`
`CERTIFICATE OF AVAILABILITY OF A CERTIFIED PATENT DOCUMENT INA
`DIGITAL LIBRARY
`
`The International Bureau certifies that a copy of the patent application indicated
`
`below has been available to the WIPO Digital Access Service since the date of
`availability indicated, and that the patent application has been available to the
`indicated Office(s) as of the date specified following the relevant Office code:
`
`Documentdetails:|Country/Office: CN
`
`Filing date: 14 Jan 2020 (14.01.2020)
`
`Application number: 2020100383019
`
`Date of availability of document:
`
`18 Nov 2020 (18.11.2020)
`
`The following Offices can retrieve this document by using the access code:
`AR, AT, AU, BE, BR, CA, CL, CN, CO, DK, EA, EE, EP, ES, Fl, GB,
`GE, IB, IL, IN, JP, KR, MA, MX, NL, NO, NZ, SE, US
`
`Date of issue of this certificate:
`
`20 Feb 2021 (20.02.2021)
`
`34, chemin des Colombettes
`
`
`
`
`-s
`Digital Access Service
`(DAS)
`
`WIPO
`WORLD
`INTELLECTUAL PROPERTY
`ORGANIZATION
`
`CERTIFICATE OF AVAILABILITY OF A CERTIFIED PATENT DOCUMENT INA
`DIGITAL LIBRARY
`
`The International Bureau certifies that a copy of the patent application indicated
`
`below has been available to the WIPO Digital Access Service since the date of
`availability indicated, and that the patent application has been available to the
`indicated Office(s) as of the date specified following the relevant Office code:
`
`Documentdetails:|Country/Office: CN
`
`Filing date: 14 Jan 2020 (14.01.2020)
`
`Application number: 2020100383019
`
`Date of availability of document:
`
`18 Nov 2020 (18.11.2020)
`
`The following Offices can retrieve this document by using the access code:
`AR, AT, AU, BE, BR, CA, CL, CN, CO, DK, EA, EE, EP, ES, Fl, GB,
`GE, IB, IL, IN, JP, KR, MA, MX, NL, NO, NZ, SE, US
`
`Date of issue of this certificate:
`
`20 Feb 2021 (20.02.2021)
`
`34, chemin des Colombettes
`
`
`
`
`
`Sea7BU
`
`NATIONAL INTELLECTUAL PROPERTY ADMINISTRATION, PRC
`
`“p
`
`Yte060Oo]
`
`ASE BAZ. WE ae: [a] AS Ja EAS AYBe AB SEI AS
`
`HA
`
`i
`
`‘s: 202010038301.9
`
`Hie SAN: Re Al]
`
`ROW) Ge PR: RRM S FLEE DB PED Fa}
`
`Hf
`
`i
`
`H: 20204F01 5 144
`
`Him OA Ba RR ZS
`
`AW ABkigtb A: Sarge. oRES. 4EE. B-L-R-FATZ
`
`AC
`
`(Pb 7
`
`2020 4F 11 FA 18 A
`
`
`
`LAER
`
`| FEAD TET BR AEah GS 4 PARR BUA A Ee BAT AY
`
`aw. PRREADA RRED. SILEREN YRS4.
`
`2. ARGE ARRAN BR 1 AA, HP PR eHeS LIB.
`3. ARGEARAIBR IRM 2Y A, HYP ypkiepA A Fa: ABE
`wD. SRK BIED. BRAKE. BED. BAER. BARZAS
`
`wea. RD. SERA. PERERA. BARBRA D.
`
`2S eH. KRG. FER. HBR. HHS. OD Rie
`
`A. ORD. BRED. RAR. NFRD. WRAP. BBE
`
`AD Fo FB IELAD
`
`A. ARSE ARAB RK 1-3 PIE—-M A ie, HP PRT ARE aa
`
`Fel: THEO GH, Hite, HATHPDA.
`
`5. ARE ARF BSR 1-4 PTE— Wag ie, HP pk veyEk 7 A
`
`ERnlnon 30 FE%, Hik Bik 60 FS%, Bihik
`
`3A 100 SSM — ALK.
`
`6. ARIE ARAIBR 1-5 PAE— May Ae, HP Aah PRT ARE
`eth ayw S ES, PET ARE PHSy LS 0.5 BE%-30 |
`2%, Hhik 1 SSE%-20 FS%, BHRA2 FF%V-15 FCS%, HZBK
`
`20
`
`5 SS%M-10 SSVI AKREY.
`
`7. ARF ARAN R 1-6 PAE— Ma Ae, HP APRT AE
`
`whey 2S,RARE PF bey AS 0.5 £S%-30 &
`
`2%, Hit 1 £S%-20 FS%, BKHA2 FSE%-15 FBX, HELK
`
`25
`
`5 SE%M-10 FSV Sa
`RAD. BILDMENIN BRSnyRRPAD.
`
`8. TERMEeae, HAS ERA, TRA ERASAAR
`
`BS FLEAREMNTA
`
`Ly 2H
`
`9. Hil & TARE oe ZS 4 HIE, FLIES HI RK Rie. BAL
`PRENSA 4 & RAH YR.
`
`1
`
`CIF191267-2
`
`
`
`10. FRIAR ARAN BRIM AK, BPMHRAGA BIRBK
`
`Ne A & AAA AY RR.
`
`2
`
`CIF191267-2
`
`
`
`LAH
`
`Rikho S TRBAT EP HE & EH
`
`5
`
`FX ARAR IR,
`
`RAY BARR a/R BS ALGET AMER oP TEEET OT
`
`THEA EAR A IE, RAW RH Bel ST FRM E PSP ae Zh oy, AF
`
`A tT PASH AI.
`
`Ab
`
`Fy Si S,
`
`So
`
`PLS nik a SA RH) FO BAP RS (iF OPA R). Ae
`), QeRH. BRM. ASR. MTR. HHA) 4ameA
`ByiP 6) AB Fi] FORSRA). TOP PR AR A @ AAeH AIK.
`AQ, WHR OCBAA =AKZMH ( Hazardous
`
`Effects of Titanium Dioxide Nanoparticles in Ecosystem, Syed Niaz Ali
`
`Shah et al., Bioinorganic Chemistry and Applications. Volume 2017,
`Article ID 4101735, 12 pages )##- 4% & A444RR ( Titanium dioxide in our
`
`everyday life; is it safe?, Matej Skocaj et al., Radiol Oncol. 2011 Dec;
`
`45(4): 227—247)(Titanium dioxide nanoparticles: a review of current
`
`20
`
`25
`
`toxicological data, Hongbo Shi, Particle and Fibre Toxicology volume 10,
`Article number: 15 (2013)) .
`Alike, BRA TARE me (wT) RELA ARAE
`AA BAA.
`RARW AN ARR, RR Ao/R BS ILIA] VA VET AL dP
`MET SP OARS. ARAB AEM. HAL, RRAS
`FUE BYEF AAG, He A ALA APR LER Ro, FP LIRA
`riry Se ME TF] RR
`
`RA AS
`
`1
`
`CIF 191267-14
`
`
`
`AR ABA Reap ET FARE me eh aPK
`
`MEE A A BARAATE, PPRADHRP. SB FLAME TIA
`
`TSW.
`
`RAW OFA MHRA ew, Halt TAS
`
`wy, LASeAaERH, FRA AERHSH A Rie. SILRMRMEMN
`
`ay ay Rw RRA. BILD RENIN HS ym.
`
`RAW HALA AHAB SRA YF EAMES ce Zh Sy, AFH
`
`RAKWNGHF PMSA, HLASRMOR REY. SILEPAE
`NARS aE A A EAROY
`ABA A BS A Ag be RO A) IK RAG AY TLREP oe BB
`tn, AEMPLS.
`
`A ape
`RAW FB Rie ET ARE bh SP RRR
`LEME AG EPPA ARE, PPR ea A RR ED. BS FLIP MIE MIN
`
`Haw .
`
`iya
`WARP, ARE SF RRP ee” RT. AE, FER
`
`Aw t45 7 F
`
`20
`
`25
`
`bechowatpe RR SRR” RHR ARRKRAR YN RD. ER
`.PRHAK. REAM. KoidporubibyengohIeAK
`
`BE SAGE Ie LARP. CPR ARRRRAAY. RSE,
`
`Re (HweRB. MKB. BRK. HE. DAB. BRAS. 1B,
`ae RE ER. BARRED ERR. BA. KR, PER. HS.
`BeRS. DOR RK. RR. RA. MH. WR. BMPR A) FH
`BK, Th 1h BAB Oe FRR RIED.
`AP EPIRA KW KH) LISA FURR:
`1) WRAP HY:
`2) HARA K. BIER RM ASIA AVARP, VARI!
`HL FF RUE Le aD Fe A in 0 BS
`
`2
`
`CIF 191267-14
`
`
`
`3) EAE, REA KABRABERSEAE YP AEF;
`
`4) BR PWM BAVAARRAE. EAR Fee;
`
`5)MetAhASHAUR TY MOKA S ERPS SB;
`
`6) Fits, KARASFE ST RAP LEK;
`
`7) MUR EKREARSRYD HB, rt SRRARRE:
`
`8) PREM, FwRA BOHRA. AERA. FAPTRE
`
`Fo/B IA ARP IRS;
`
`9) BURP BRAY HE.
`
`5 FP PRA KY A-P KP LGA FPR:
`1) AFAR IR ERE L917 For;
`2) KIPRPIRRAKZHRR, FRA DW RR;
`
`3) AFAR ADPER BAK AAT
`4) it HA KF eH Hg A RY bis FL feo/BR RAD AAD HE PE
`
`Pe fe 2m 04 ZF Ee:
`
`5) 1%) AAR SAID BH BM KG RA TS RGB EAD RAT;
`
`6) A BSR SHIRE SH BLK;
`
`7) AARP RAF Rice;
`
`8) BAK FRY ee.
`
`A ANH, HARA IKAR SAMBA LR SER, RENE
`
`20
`
`See, Atk, BA HBERAKREWN RARE TAREE Be,
`
`AE BEA PVA Ri ERE AY TOPE i, EB er TER
`
`ani
`
`PA FR AWW RRA IRA PRRSEL, Wa EARRX.
`FERARV MIR KGARP, HAPS FLAP.
`wR, FR SS ALE” RIG IRAP RS AP DDFB
`7K feBat EPIRA ARDY REMADE TUS PALM HR
`
`25
`
` .
`
`AREA AA, WP ARB at AAT oe DRRR9FO
`
`B AP AD D> ADS (1h ho AD BS Fe EAD FB) SFE). RRA
`
`3
`
`CIF 191267-14
`
`
`
`FSET ROKR RAP SIL. RREPMETARTASR. AK
`
`BS. BAR, ME. BAA. MARRS. DA. MAA, MR BR,
`
`UPR BRR. RB. KAR, FER, WB. MRR DR. BAR,
`
`mR. RHA. MF. WRKRPRA.
`
`PR AE BS FU GE AYRA AL WY HIE FY VAR LAB LAR
`
`BUD
`
`UAE A BR (Gh ho ER Fo FRO) OK AREEAPE
`
`( 15) eo ABE A BOGE ) SLT KAR PR EAD EB GLUE AD, VAS
`
`ALBa BE HY
`
`PY AS i ADAS. VA ES) Fo A SB FLAS GL2E A. HEU,
`ENA KE KGL Fe) GL, MHEFGLAY AR HA AMI A Bi wee
`Bl AE
`
`ERAUABRARGAR PS, AAV PIR SLAMARE
`FLAT A 4EA 0.0lum-S5um, 4i& 4 O.05um-2.5um, 2414 A O.lpm-lum
`SA4L,
`
`BVA 1% JF) 42 4h We SE GkBEL FR GL RE
`
`ERARVU WRIA RKMEARP, RRP 1A WY SD FLA HIE
`
`0.5um-200um, 44:% 4 1lum-100um, #244:% 4 2um-60um.
`BY VA 2it OKT AEX (BeckmanCoulter LS 13 320) m)-@ #5
`
`20
`
`4B.
`
`ERA P, RP TOAAA FA: ASRY. HAKSRDM. B
`
`RED. BBR. BBR. HRARBABSRD. DARD. BH
`Rey. SHREK. BARMERA. Beep. KARR.
`PER GED. HRD. PA BD. DRED. SKE. BK
`DD. RAED. MPR. DRED. BRED PRAY.
`FERRY Ai REA EP, RAY PARI YS FLA PRR
`
`25
`
`BRAG Ay eR RTL XK.
`
`WAR A, RE “AERA” RTF RKAGEARK MERE
`
`Bt RIE F609 EAS 4.
`
`4
`
`CIF 191267-14
`
`
`
`FE PSA RA Se MA EH ALK.
`
`ERR MORIA RGAR PP. HP ET EME F, PASI P, TF
`
`DLEAT SUMP, BABAK30 FSM, Hit Bik60 FE%, #
`
`Rik Bik 100 FSA — AK.
`
`ERARU WMI REA EP, FART TARE cel ay, FF
`
`RAGASMH RES, AREY E O05£E%30 FEM, HA1E
`
`E%-20 FF%, LRHA2FEM-15 FE%, HALKAS $F%-10
`
`EE%,
`
`FELRARV MIR KEA RP, FART TAME ce Say, FF
`RAFGUASMH REE, SILAS O5CE%30FE%, Hi*1 E
`
`E%-20 FE%, PHA2 FEM-15 $€F%, HALKAS €F%-10
`
`£E%,.
`
`AA] TRE Se eh an, APSTLS
`PEA. TRELAL. RDS MA). HAAR) Fe teih 4 AAs FI .
`
`FEAL EADRIA,FPA EBSD,KP AE TAY DR.
`
`EN AHRAKRT HAD HGH, RPK, BPM KRBATE.
`
`2 i& 09 ER A KG) LISA AIR RRR. SERRA. — BE,
`
`ZU FU(6 48. EERGG. SKGRR A BMEMN RS.
`
`SA He, FART TAME ce hoy, HAT PASH SES,
`
`20
`
`JERG 10 BE%-25 SE% (BHT, toBee)25 SE
`
`%-50 £E%, Hid 30 FE%-50 SE%( FEAT HT, BORRE/ER
`
`—48%).
`
`FELRARV MIR KEARP, FART TAME ce hea, Here
`FRreaseyn SES, KEOLE%-40 FE%,Hik 10 $S%-30 E
`
`25
`
`2%, REA PRA15 £FE%-25FE%,.
`
`TRIB. F) FA PAR A PRARKa Kp AHe AL,
`VA ak
`APRRHIRA PG ATME PAH: S-DRRAKAT TP YHREAS,
`4% LU VA FE RID be KAKA
`
`ERR UW YRIARMABRP, HAMA AH. WA. AB.
`
`5
`
`CIF 191267-14
`
`
`
`Tai. ROTA EINNRSD.
`
`AaRt FOF AREF RAS, WAF PASM YN RES, AMA
`
`& 10S 2%-70 S$ F%, Hie 20 F $%-60 $F E%, BKhik 30 F$ B%-50
`
`2%,
`
`Ao re EA JA RRR LA KG FoRiTO
`
`AE ERKH)LBKIRT AHRRRA, AERP REO
`&&44 (sodium lauroylmethylamine acetate) .
`/] tEOR#RBR4Q. Hib #
`FA 7E RR AGAR ERAL RARE A RA,
`ADR FT AME hoy, HAT PASM SES, AHS
`
`PER) Gb 0.01 £%-10 FE%, Hit 01 SSEV-7 SEW, Hie 1-4
`
`EE%,
`
`Jo FF] GF PMA RR. Ame RPRREYMT Ee.
`LEARY AKA KMEARP, HAMAR PRA. ALR
`WB. EER AR AOE TIMERS.
`
`AaXt FF ARELe, HAT PASM YH RES, HAA
`
`50.01 £S%-10$F$F%, Hit 0.1 F$S%5 SE%, PHM 1FF%-2
`
`FEe%,
`
`JELRA WRIA RBARP, Rais ARAL. eR. GB
`
`Al. AGA RTA. HAMAR EMNHRESY.
`
`gant $F AMIRI ER4h, ikF FASEB ESE, Ral
`
`20
`
`508E%-10 EM, HAIL EN7 £S%, FAELKHM1 SEE
`
`%-4 FF%,
`
`BVA AG AAR IRA PT Fh] Ko 09 PT Ay FR 4 eA FA) AS Ho Bl AR AA AQ OF
`ARES mein, AE ARARA YF PSAP. WAR AT Bote
`WH. SMEAR NRE, LIGA HIRT I 8 AD Fe KR 9 oh(1
`25
`domaG ib.
`7KRA.ib. BZA. TH. Ae. BK
`). CTA RRA A LIAM. RARBARARA Hh APIAUR SE], RK
`Fo A LPR APT VA VME ROE EDEL MRS ADS.
`
`SIAR 09 KY] CLAS AIR A ARAN. eSRUE. ST Oa,
`
`6
`
`CIF 191267-14
`
`
`
`tH (MRA) . CARRSP. PEBR (if te LAB. KR
`
`MEAG. AC REAR A RHEE) . PRRRRDREMNNSY.
`
`Br FS A) eo 48 AT ek AARE oe IE RR ERA ATR AE oe
`
`UR at. SRA RE) LISA KHIR FM BRAPY RY OG. HH
`
`5
`
`RRP RAG. PCRRAPROABRENHNREY.
`
`AGA WARP ALISARIRS (HRA. SHAR. BKRER. BE
`
`"ENT ATS 4.
`dT He FO KY) LISA AIRS BRAMAARLRS YD.
`Fe AA Fi] A KY) LISS AIRF CAB.
`FERRARA RGARP, THEM wo, AAT
`28S 4h) LS:
`
`HO FT ARES ee, ART PS BEE, 0.5
`
`£E%-30 FS%, Hik 1 FF%-20 FS%, FHA2THY-15 FS
`
`%, HEERIAS CZ-10SSVHRKRED,
`
`-HXT TF AMA E eho, FRET PASM SSS, 0.5
`
`FF%-30 FS%, Hik 1 FF%-20 FS%, FWMA2 FSH-15 FS
`
`%, LA BRHIAS FE-10 FSH SIL,
`
`ALi, FO TT AAME PF Sew, HAT PSH
`
`£e, 0OFS%40FS%, Hit 10 £S%-30 FSos, HER15
`
`20
`
`BE%-25SF SAK,
`
`HA Xt TR EME PY eee, AT PASM SESE,
`
`10
`
`FS%-70 FS%, Hik20FF%-60 FF%, Bhik30€ F%-50
`
`SA TRIE FI
`
`25
`
`ALi, FAR PF ARES Hoy,RTHRE
`&, 10 S%-25 SF E% (RBH TP, te AE) R25 EE%-50
`EE%,Hhik 30 €E%-50 SEN ( BEAT, toRMRG/M)
`BH,
`AX} FARE SP eh, AMET PSBES, 0.01
`
`FEW-10SEM, Hit0.1 SEW-7 SEM, SHIA FEN4 SS
`
`7
`
`CIF 191267-14
`
`
`
`YN) RD Ee HEF,
`
`ADT PT ARE ee, AT PS See, 0.01
`
`£E%-10FE%, HiA0.1 $S%-5 SE%, BHA] FS%2 SS
`
`Ny 24 AA FH),
`
`FAP
`
`(£iAwL, FAR TT AMAE SP we hoy, MT PSH RE
`
`2,08 %-10 £S%, “HiL0.1 FE%-7 SEM, RHA] EEW4
`
`EEN AATF
`
`KAR V ILRPME SPoy, HRT PAS, HAS
`AaERH, ZAECRASHARED. SILRPRENMREVAH
`RED. BALM ENTAILS WAM.
`
`LRA RAR GASP, ZASWMKRASA~AMALA GE
`BRAT
`JA A 4 FARE re Sy, FB oe eo HY MEY TP
`Sp, TART KARATEE P me, RHETT, HAAKRA
`BP. ARB FAR, FAASRA ALAM AM, Mah
`
`45 4) 2 Ae BAG AY Oo PE. RB, TARE (FIAT HY)
`
`ABR FARMER me (ARTHASTe), HOR Fe
`
`AE ub AF EE A) — BUC AVE A OE AT aATORE de (4A
`
`AE) FALE ERE. 4M, RRA AS FLHyEARS
`
`20
`
`AREAS HY AE RAT.
`
`FERAVMP,
`
`“FRAGA TAMEce” FREER A PAA
`
`(RATE EL SE RMR ACER TRIGA Pe. A,RARTO”
`FLAG EERAY LARRABEE. ARR URFFERRAROF
`TARE CRT) 0 OPA? AoA, aR
`
`25
`
`Imfeld, Th. N., Identification of Law Caries Risk Dietary Components,
`
`I198pp., H.M. Myers (ed.), S.
`Monographs in Oral Science, Vol. 11,
`Karger AG, Basel,
`1983
`45 i& & 4% YE 14 * H&K (Toothfriendly
`International’s Standard Operation Procedures)i8 ii 1 J&A pH Wik R
`Mi. FLAP AREAL AEP, A RAAB BEA DRM
`
`3
`
`CIF 191267-14
`
`
`
`TA TARE oe C4 eT) FA Fel 0 30 APA, WEF
`la)S209 pH. RAM RMA RAM RMR GY30 4A aK
`Ay th at 4m AK 7 Ve) HEH pH AAT 5.7, WIAA F FMAME FH se (FF A
`TE) LAURA. FER EAP AEAAIR A YD.
`
`4y Ade, RAHA RIA BR Fo S FLD A A EP a 2
`84, Asha HAE TPREF oe (4TO) ZG 7 TA44 pH
`REMMRENW RK (pH5.7). ERAUNRARMARP, BH
`SARI TRE ob eh ean (FF MET PALS) Ze, F le) HEA
`pH HIF BRT 5.7, Hhithh, AW RAR TEMEP Ze, Fie
`BENQ pH A 5.7-7, Bik Hy 6-7.
`yy VAARGE Tawakoli et al., 2015, Swiss Dent J, 125, 1210-9 ¥ 4Hi#é
`A EM IK A ARE oe 4 BAR
`RAWY AAG ARR EM. SILEDMREMNM RSW A
`BE BRAT R Hi] & ABAE TRE ob 2 Sad ( ik FT PLSD ),
`a) aS HRAA AULAEH A ATHR TAREA
`
`HW) FAVA ELL B BEng Re RAE RE. A He, A Rie Ae S
`
`ALi Apt ARS LARA AAR, HARA Ee SRM,
`
`Alt, BAW A HE A Al he HY RE SY FT FER ME oe ZB
`
`ay (FF A ce ROR RELY FPS) NAIK, Ham Ri
`
`20
`
`WD. SIEPRMEMNRS WHA B 6M YR.
`
`EN RMARP, RRA AEA BRIALAA Ee
`
`BRAT OY RR
`RAY YT BME hoy, AT PS, Dv ity
`A Ap A ALAR ME FE So RR ARIK AS Am Bl] KARR Bike 4 HEILBP RK HI
`&
`
`25
`
`RAVE GR HRY AIRY TF FRE oy, FF A
`LAF FASw.
`IL ALARA FPA Fe RAVIDLW AAW, MIA, eA
`Fo LHe) GFA RFER RW,
`to REET AAPARATA).
`
`9
`
`CIF 191267-14
`
`
`
`Bet FS) ta] Sevit
`
`Al: $ 3Le37 BK 449i BF BGA.
`Al2: A Keee) 1 HARERD Hl RF a pH 2M Ze
`
`AR
`
`AR »
`
`3: AKA) 2 4S FLBAY Hl RT OY pH Mes
`
`FEVAF ERP, TEVA ee tt = ae:
`-# Roquette %§ 324449 Neosorb 70/70B ( 44 1h RAF )
`-# Sinopharm #8 ve 1h) Fl t#2hABRAA
`- Ashland we4hajs Kk F RAK
`-4) Sinopharm ® e214 a9 CAE
`- TIFF ® vetiny #a4t
`-# Sinopharm ® ve (to) 4% 4A 4
`-4) Sinopharm # Je 1t o4 x ¥2 HOP OP BS
`-4 Sinopharm ® oe 1th 4) x} HAY OR A
`-4) Sinopharm # 324 84 3 RUBEAA .
`KH) 1 PARI A A PASE BRHEARED OP Pp
`
`RRA ENR —-PRAPRANARAP MH.
`
`K 764) 2 PARA) AY BS FART BREARE VA FO ER PRS
`
`FR ALF 89
`
`lL. RASSBRAD BF AMRRKPEDAS EA 26%.
`2.127) 3.3%NaOH ik ep RAT AY pH WAP ZB 7.0.
`3. AAA IAA YH a-7€ 498% (Novozymes % Liquozyme Supra,
`2.67mg Be/e Fie) , FE SSCK RM 4H,
`4. 2 ith A SUH ARIE pH WAAZ 3-3.5 MAPLE Rw HRI)
`
`EK
`
`10
`
`CIF 191267-14
`
`20
`
`25
`
`
`
`. Fl 3.3% A Ae AN RAF pHHA4.5-5.5.
`| HEAD AR AT HS HP B29 25°C,
`
`EYE RAT UA GRAS BS GL ieHt
`
`AK RR RIA IE.
`
`.
`
`5 6 7
`
`8 9
`
`. TRAV RFR BE GR BET RR aR By A BEAK 12% AHP AR.
`
`BD FLRG A BR GE a09 434RR eo 1 Pa
`
`KH GV: PT A A PRG BORED Fl] A TP PE ME Fo BF
`
`10
`
`1 BT WGK TO PE AF
`
`% GEBRANGFF)
`
`fe ay rk(%)
`
`45.00
`
`Neosorb 70/70B
`
`CAMB LL SLAF) (PREF)
`
`BERD (6 CHBEBD
`
`AERGRAS LA)
`
`BP RARE BRAM)
`
`aes
`
`
`BATUAH )
`
`HEARGA (EPRI)
`
`3FERED RP BGGBF)
`
`3}ZRRBSBF)
`
`1
`
`ARAVA FA ERS T FH:
`1. it4 50C FA ABAAN Fe % AUERGA AARKP RSA
`
`15
`
`‘Ae 3
`YE YR
`
`CIF 191267-14
`
`
`
`ih at4 80°C FASJB #) AS 4B] NEOSORB 70/70B WaBFA
`
`PRIS ORR. Re, HRERAARELHE SOC, HEAmit
`
`A AEE EK PARR FP REE R
`
`3. BAER RIS BARR. IRFSD a B30 24.
`
`SLE ULE 5 SP4P
`
`AS Aa — BE I BREAD ILS 104K.
`
`Aa Hy PR ERED, BLS 1074P.
`
`oNDAMS
`
`WAS Aa Fie BRBRB A YS Re Fo CR, PRIS LS 3 op4?
`BUS eeAARIFEAE FIRES 5 4.
`78 iL1% JF] pH 26 WAR YELL & E( Imfeld, Th. N., Identification of Law
`
`Caries Risk Dietary Components, Monographs in Oral Science, Vol. 11,
`198pp., H.M. Myers (ed.), S. Karger AG, Basel, 1983) MiKPT HT FH
`“FRAWRRE” . ERAS ASMM SRA P Miksa.
`2& Re A 2 bem.
`wA 2H, KARA pH HAKARW, THMLCRA AHP
`Bae AE RAY 30PPA, REAUWAS, HHH F Ml Bt pH IAT
`57 RK. ZEKE CW) Fo Gehry (PC) FAM 4 ll BE pH 42920
`VA PPE RT RR CF 10%RAB AR ) AEG 7 A BtpH WEIR AMAT 5S,
`JEW SRA SOE MYER. A SIRRE BMG pH wR
`WIAA F Fe LER ZARA.
`BE, 48 FF BEit BOKaD i] PO a AE ae 9 AE EA ( pH 2 5.7).
`ARE VA EO SE MY GK AR A A ORaD | A OP aE oe 9
`
`(RDA) .
`
`AKTPEBESRNSAEOAR ee BERG WEREEKKARATbE PPP
`Fay 32K.RUEA ART PRR Bea 8 il A HUA F
`25 a4P, BAMA 1,500 ok 4 BL (447 60K). MF Kh AF
`ASN. ABA F fill, RIA LA FG) Ze By 4 Fh FT F\( Paro M43
`medium, EsroAG) . BAAR LF PA oe SY RAR RHE
`Rt]9 RAL. A PRA IS, 125 g FH. 40 mL A LRFe SOUL
`
`12
`
`CIF 191267-14
`
`20
`
`25
`
`
`
`bE )% RF) (Fluka Chemie ) 44k 5 4P. tit + 10 g ISO Sident. 50 2g
`HOP RAYA AMR(0.5%) . Hib (10%) FARE RIA Hi] RARE
`
`RA, MFI VA PIAA “SBE” IRRMEAT. Ho RIB ATARI RHE
`
`FER RAY, RRA PRA, RUG RARHEB RRA. SKIES, RM
`0.5 9Hite RA, 3) Phosphorimagers® (7 TAA#) WMS
`“BSAP Rw” (dpm) #& °P 4a4t. MIT GRA P MPP HE eM IK
`jP So FT ALAR AR BGR BE. IE SEIS” FRR RHEE RAST
`
`aeR-P Ha, Hie A 100. Petes ag sart TAM BARRE AE
`
`HE FERAL AD AS re
`WIR Ag A OE oe 9-3 RDA (84% 2.05, KERALAER
`KD | MO TOI AY BGR”
`(RDA 0-20) FHF #H ( Tawakoli
`
`et al., 2015, Swiss Dent J, 125, 1210-9) .
`RK UE AE RGAE), ARS EB Rip il BT PT FA BARE
`Al, AREA RBG FORT A , Atk “THAR” .
`
`3 el 2: spat BS FLBR ee] A OP 4 aEE oe OBE
`
`R27 BT BMI TSH GF.
`
`
`
`BAP
`JtE aE (%)
`
`
`Neosorb 70/70B
`
`45.00
`
`CRA LL SLAP) (RIF)
`
`
`aK
`
`20.00
`
`3 ALR BRAY (A EAAIEA)
`
`
`
`FY AEIRLERAA7 TF)
`
`RPRAAR HAA)
`
`a F
`
`ATAF)
`
`BEEAAA (BHRFI) )
`
`0.2
`
`13
`
`CIF 191267-14
`
`
`
` 6 BOERZA (di FEA)
`
`#2
`
`ARG KF) LAA RNS AT PH, FPR BAR CIR AL
`
`Se JR Be READA
`42 R76) 1 PAD pH MARA A KMART eH STR RK
`WIRE” . EAA OKBRYH ARH PP MAPS.
`
`ge R40 3 Pa.
`we 3 Prom, PAP BRIA pH WMARW, FS FLABK ED Fl MR
`A eAee EP 204s 7 RA A 30 Pa, LRRARZE,
`33) 542 F Ma) st pH (KF 5.7 LKR. HKEA CW) Fo she CPC)
`Hy a) FM) BEpH A929 eV BAM RT RR (CA LOMMAAR) BG TIA
`SE pH MIEKA 5, HEAT RAAB ERD. AMR
`5 BARRE pH HARE WR RSNA YD.
`whe, 4S FURBREADOF aA EK, ( pH 2 5.7).
`ARG KF) 1A EM IAS A SD FL BARE AY i] OF A de
`
`4) RAR (RDA) .
`
`MiX a1 BS ILSBRAD Hi] A TA RDA164 1.3, XE
`tA IEA EU “RY BAR”=(RDA 0-20) F FHF ( Tawakoli et al.,
`
`2015, Swiss Dent J, 125, 1210-9) .
`RE HE PE RGEW , RA BS FLAG BR ea el] a TM OT RA EB
`
`20
`
`AVE FA, FREER ACI TRAD, Ate “FBAR” .
`Seve: SRIEW, HHA RADA SILEDPATET TE PA EAR
`AY, PAG A ep ET EP AY BB a ME Fo OE EH) BIR,
`
`14
`
`CIF 191267-14
`
`
`
`GLA Mi
`
`CIF191267-3
`
` 1
`
`
`
`
`ee
`
`ONRt
`
`CIF191267-3
`
`
`
`
`
`<é
`Teees
`le
`ae
`ee
`
`q
`
`RK)
`
`
`:|SEdichedtncbadbnbivininicleisbeaiabideeee
`iiiaaaieeeeilegpit
`
`x:
`
`ae
`
`CIF191267-3
`
`
`
`
`
`™,
`
`™ =
`
`WIPO
`WORLD
`INTELLECTUAL PROPERTY
`ORGANIZATION
`
`DOCUMENT MADE AVAILABLE UNDER THE
`PATENT COOPERATION TREATY (PCT)
`International application number:
`PCT/EP2021/050454
`
`International filing date:
`
`12 January 2021 (12.01.2021)
`
`Documenttype:
`
`Documentdetails:
`
`Certified copy of priority document
`
`Country/Office:
`Number:
`Filing date:
`
`CN
`202010038301.9
`14 January 2020 (14.01.2020)
`
`Date of receipt at the International Bureau:
`
`03 February 2021 (03.02.2021)
`
`Remark: Priority document submitted or transmitted to the International Bureau in compliance with Rule
`17.1(a),(b) or (b-b/s)
`
`34, chemin des Colombettes
`1211 Geneva 20, Switzerland
`www.wipo.int
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
